Startups
Knome delivers the bioinformatics infrastructure and insights researchers and clinicians need to build industry-leading NGS testing programs.
Overview
Location
United States, Massachusetts, Cambridge
Employees
51-200
Total raised
$13M
Founded date
2007
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 23, 2014 | Knome Closes $13M Financing | Knome, Inc., a Cambridge, Massachusetts-based provider of human genome interpretation systems and services, closed a $13m financing round. Backers included current investors. The company intends to use the funds to expand its genomic servic... |
| Nov 15, 2012 | The $1,000 genome question has turned into, “How can we understand this data?” | Life Technologies and Harvard Medical School professor George Church may be the only ones who have officially thrown their hats in the ring for the $10 million Archon Genomics X Prize, but many others have made ambitious promises in the que... |
| Jun 5, 2012 | Genomic analysis company gets $250K JumpStart investment | GenomOncology labels itself as a “genomics-as-a-service” business. The company predicts that the key to its success lay in its ability to quickly and accurately analyze data and report it to customers in an easily understood format. Knowing... |
| May 25, 2012 | Software fast enough for custom-made cancer treatments? | GenomOncology is on the cusp of launching. It’s started raising money for salaries, software costs and tumor sequencing. It wants to work with biopharmaceutical companies, cancer research groups and academic centers. For biopharmas, the ide... |
| Aug 2, 2011 | Knome Raises $5M in VC | Cambridge, MA based life science company specializes in the interpretation and comparison of human genomes. >> Click here for more funding data on Knome >> To export Knome funding data to PDF and Excel, click here CAMBRID... |
| Aug 24, 2009 | Complete Genomics seals $45M for cheaper gene sequencing | Complete Genomics, provider of supposedly cheaper and faster DNA sequencing services, has raised $45 million in a fourth round of funding — a huge amount for a biotech company in today’s economic environment. Based in Mountain View, Calif.,... |
| Aug 24, 2009 | Complete Genomics seals $45M for cheaper gene sequencing | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Complete Genomics, provider of supposedly cheaper... |
| May 18, 2009 | Knome Offers Thriftier Gene Sequencing | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Knome, a personal genomics startups located in Cambridge, MA, announced today the launch of its newest product, a partial genome sequencing package called KnomeSELECT. The ser... |
| May 4, 2009 | 23andMe gets $11M boost to decode your DNA | 23andMe, the company that deciphers consumers’ genomes for them, has raised $11 million of an anticipated $24.26 million second round of capital. The company was cofounded by Anne Wojcicki, wife of Google co-founder Sergey Brin. The firm di... |
Show more
Reviews 0
FAQ about Knome
When was Knome founded?
Knome was founded in 2007.
How much funding has Knome raised?
Knome has raised $13M in total across 1 funding round.
What has the press written about Knome?
Parsers VC has collected 20 articles mentioning Knome, among them “Knome Closes $13M Financing” (Jan 23, 2014) and “The $1,000 genome question has turned into, “How can we understand this data?”” (Nov 15, 2012).
Is Knome still active?
Yes, Knome is active; its latest activity on Parsers VC dates from Feb 9, 2016.